CClinicalTrials.gg
CompletedNCT00706979Updated Dec 9, 2011Results posted

A Novel Treatment to Boost Quit Attempts and Cessation Among Unmotivated Smokers

An interventional study of Practice Quit Attempt plus nicotine lozenge and Practice Quit Attempt only in Smoking and Smoking Cessation, sponsored by Medical University of South Carolina. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2011-12-09.

Sponsored by Medical University of South Carolina · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
849
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A sample of smokers who have no current plans to quit will be recruited for this study and randomized to one of two intervention conditions:

  1. Practice Quit Attempt (PQA) aided by brief advice and self-help materials, or
  2. PQA aided by advice and self-help materials plus nicotine replacement therapy (NRT).

This study will test whether adding free nicotine replacement therapy to brief advice to undertake a practice quit attempt will motivate more smokers to make a serious attempt to stop smoking than brief advice without NRT. All treatments and assessments will be delivered via telephone and mailing. The primary outcome of interest is the incidence of a serious attempt to permanently stop smoking made over a six-month study period.

Our specific hypotheses are as follows:

Hypothesis 1: Helping smokers to make a practice quit attempt aided by NRT will result in a higher incidence of making a serious effort to quit smoking permanently, compared to an aided practice quit attempt without NRT. We also expect provision of NRT will increase point prevalence abstinence at 6 month follow-up.

Hypothesis 2: This relationship between NRT-aided practice quit attempts and quit behaviors will be mediated by a) increased smoking related self efficacy, b) increased belief in the efficacy of NRT, c) fewer concerns about adverse events of NRT, d) increased social support for not smoking, and e) less withdrawal distress and craving during the practice quit attempt.

02

Conditions studied

  • Smoking
  • Smoking Cessation

Keywords

  • smoking
  • smoking cessation
  • nicotine replacement therapy
03

In context

Lead sponsor

Medical University of South Carolina is the lead sponsor of 852 studies on the registry; 165 are open to participants now.

Of its 128 completed or terminated interventional studies of FDA-regulated products, 101 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Current cigarette smoker of at least 10 cigarettes per day
  • Interested in quitting at some time
  • Not currently interested in quitting smoking
  • Access to telephone (home or work) for 6 month study period

Exclusion criteria

Exclusion Criteria:

  • Monthly cigar, pipe, or smokeless tobacco use
  • Current pregnancy or breastfeeding
  • Recent cardiovascular distress
  • Phenylketonuria (PKU)
  • Previous use of nicotine replacement therapy (gum, patch, lozenge, inhaler, or nasal spray)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
849 participants (actual)

Study arms

  • Experimental
    1

    Practice Quit Attempt plus Nicotine Replacement Therapy

    Other: Practice Quit Attempt plus nicotine lozenge

  • Active comparator
    2

    Practice Quit Attempt only

    Behavioral: Practice Quit Attempt only

Interventions

  • OtherPractice Quit Attempt plus nicotine lozenge

    nicotine lozenge, 2 mg or 4 mg

    Also known as: Nicotine lozenge, Nicotine Replacement Therapy (NRT)

  • BehavioralPractice Quit Attempt only

    Practice Quit Attempts (PQA) message aided by brief advice and self-help materials

06

What researchers measure

Primary outcomes

  1. A Serious Quit Attempt in Which the Participant Intends to Permanently Stop Smoking

    The primary outcome was an attempt to quit smoking for good. To distinguish from a PQA, we specifically asked participants if they tried to quit smoking with the intent of quitting for good. Quit attempts were defined as any self-defined attempt to quit for good.

    Time frame: From study enrollment through six month follow-up

  2. A 24 Hour Serious Quit Attempt in Which the Participant Intends to Permanently Stop Smoking

    Serious quit attempt of \>=24hrs, which fits the CDC's definition of a quit attempt.

    Time frame: From study enrollment through six month follow-up

Secondary outcomes

  1. Abstinence From Cigarette Smoking, Where Abstinence is Defined as Self-report of Not Smoking at All for 7 Consecutive Days

    Time frame: At any point during the study

  2. Abstinence From Cigarette Smoking, Where Abstinence is Defined as Self-report of Not Smoking at All for 7 Consecutive Days

    Time frame: At 6-month follow-up

07

Results

Posted Dec 9, 2011

Participant flow

Participants were recruited from 1/2009 - 2/2010 via the internet from an email database of potential enrollees provided by a market research firm. Eligible participants were mailed an informed consent and asked to return a signed copy if they wished to participate. Research staff then made calls to initiate formal study enrollment.

Participant flow — Overall Study
MilestonePractice Quit Attempt Plus Nicotine Replacement TherapyPractice Quit Attempt Only
Started426423
Completed426423
Not completed00

Outcome measures

PrimaryA Serious Quit Attempt in Which the Participant Intends to Permanently Stop Smoking

The primary outcome was an attempt to quit smoking for good. To distinguish from a PQA, we specifically asked participants if they tried to quit smoking with the intent of quitting for good. Quit attempts were defined as any self-defined attempt to quit for good.

Time frame:
From study enrollment through six month follow-up
Reported as:
Number · participants
A Serious Quit Attempt in Which the Participant Intends to Permanently Stop Smoking
participantsPractice Quit Attempt Plus Nicotine Replacement TherapyPractice Quit Attempt Only
A Serious Quit Attempt in Which the Participant Intends to Permanently Stop Smoking208168
Statistical analysis
  • Practice Quit Attempt Plus Nicotine Replacement Therapy vs Practice Quit Attempt Only · Regression, Logistic · p = 0.008 · Risk ratio (rr): 1.2 · 95% CI 1.1 to 1.4
SecondaryAbstinence From Cigarette Smoking, Where Abstinence is Defined as Self-report of Not Smoking at All for 7 Consecutive Days
Time frame:
At any point during the study
Reported as:
Number · participants
Abstinence From Cigarette Smoking, Where Abstinence is Defined as Self-report of Not Smoking at All for 7 Consecutive Days
participantsPractice Quit Attempt Plus Nicotine Replacement TherapyPractice Quit Attempt Only
Abstinence From Cigarette Smoking, Where Abstinence is Defined as Self-report of Not Smoking at All for 7 Consecutive Days8263
Statistical analysis
  • Practice Quit Attempt Plus Nicotine Replacement Therapy vs Practice Quit Attempt Only · Regression, Logistic · p = 0.09 · Risk ratio (rr): 1.3 · 95% CI 1.0 to 1.7
PrimaryA 24 Hour Serious Quit Attempt in Which the Participant Intends to Permanently Stop Smoking

Serious quit attempt of \>=24hrs, which fits the CDC's definition of a quit attempt.

Time frame:
From study enrollment through six month follow-up
Reported as:
Number · participants
A 24 Hour Serious Quit Attempt in Which the Participant Intends to Permanently Stop Smoking
participantsPractice Quit Attempt Plus Nicotine Replacement TherapyPractice Quit Attempt Only
A 24 Hour Serious Quit Attempt in Which the Participant Intends to Permanently Stop Smoking185143
Statistical analysis
  • Practice Quit Attempt Plus Nicotine Replacement Therapy vs Practice Quit Attempt Only · Regression, Logistic · p = 0.004 · Risk ratio (rr): 1.3 · 95% CI 1.1 to 1.5
SecondaryAbstinence From Cigarette Smoking, Where Abstinence is Defined as Self-report of Not Smoking at All for 7 Consecutive Days
Time frame:
At 6-month follow-up
Reported as:
Number · participants
Abstinence From Cigarette Smoking, Where Abstinence is Defined as Self-report of Not Smoking at All for 7 Consecutive Days
participantsPractice Quit Attempt Plus Nicotine Replacement TherapyPractice Quit Attempt Only
Abstinence From Cigarette Smoking, Where Abstinence is Defined as Self-report of Not Smoking at All for 7 Consecutive Days6857
Statistical analysis
  • Practice Quit Attempt Plus Nicotine Replacement Therapy vs Practice Quit Attempt Only · Regression, Logistic · p = 0.3 · Risk ratio (rr): 1.2 · 95% CI 0.9 to 1.6

Adverse events

Collected over Adverse events were collected in the Practice Quit Attempt (PQA) + Nicotine Replacement Therapy (NRT) group only. They were collected at every follow-up study visit, which included 5 time points over a 7.5 month (32 weeks) period.. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Practice Quit Attempt Plus Nicotine Replacement Therapy—0/426 (0%)179/426 (42%)
Practice Quit Attempt Only—1/423 (0.2%)—
Most frequent serious events
Most frequent serious events
EventPractice Quit Attempt Plus Nicotine Replacement TherapyPractice Quit Attempt Only
DeathRenal and urinary disorders0/4261/423
Most frequent other events
Most frequent other events
EventPractice Quit Attempt Plus Nicotine Replacement TherapyPractice Quit Attempt Only
Nausea/stomach upset (dyspepsia)Gastrointestinal disorders80/426—
Throat irritationGeneral disorders60/426—
HiccupsGeneral disorders45/426—
HeartburnGastrointestinal disorders23/426—

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Practice Quit Attempt Plus Nicotine Replacement TherapyPractice Quit Attempt OnlyTotal
<=18 years000
Between 18 and 65 years382389771
>=65 years443478
Age Continuous
Age Continuous(years)Practice Quit Attempt Plus Nicotine Replacement TherapyPractice Quit Attempt OnlyTotal
Mean50.5 ± 11.850.7 ± 11.450.6 ± 11.6
Sex: Female, Male
Sex: Female, Male(Participants)Practice Quit Attempt Plus Nicotine Replacement TherapyPractice Quit Attempt OnlyTotal
Female266279545
Male160144304
Region of Enrollment
Region of Enrollment(participants)Practice Quit Attempt Plus Nicotine Replacement TherapyPractice Quit Attempt OnlyTotal
United States426423849
08

Study locations

No study locations are listed for this record.

09

References and documents

Publications

  • Carpenter MJ, Hughes JR, Gray KM, Wahlquist AE, Saladin ME, Alberg AJ. Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit: a randomized clinical trial. Arch Intern Med. 2011 Nov 28;171(21):1901-7. doi: 10.1001/archinternmed.2011.492. PubMed 22123796 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 9, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00706979
Lead sponsor
Medical University of South Carolina
Collaborators
National Institute on Drug Abuse (NIDA)
Responsible party
Sponsor
First posted
Jun 30, 2008
Start date
Sep 2008
Primary completion
Oct 2010
Completion
Oct 2010
Results posted
Dec 9, 2011
Last update
Dec 9, 2011

Study contacts

Matthew J Carpenter, Ph.D.
principal investigator · Medical University of South Carolina

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion